Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...
2024-03-20 14:45:11 ET Image source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q4 2023 Earnings Call Mar 20, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
2024-03-20 14:43:17 ET Summary BioNTech's Q4 earnings shows a significant revenue drop and profitability concerns, with expectations of continued vaccine demand decline. Despite short-term challenges, BioNTech's mRNA technology and pipeline, including COVID/flu vaccines and oncolo...
2024-03-20 13:30:20 ET BioNTech SE (BNTX) Q4 2023 Earnings Conference Call March 20, 2024, 08:00 AM ET Company Participants Victoria Meissner - VP, Strategy and IR Ugur Sahin - Co-Founder and CEO Ozlem Tureci - Chief Medical Officer and Co-Founder Jens Holste...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 28.7% to $0.0887 on volume of 95,670,653 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 21.5% to $0.0243 on volume of 91,833,714 shares Oblong Inc. (OBLG) rose 45.2% to $0.19605 on volume of 60,847,1...
2024-03-20 07:33:04 ET BioNTech SE (NASDAQ: BNTX) is down nearly 5.0% in premarket on Wednesday after reporting disappointing financial results for the fourth quarter. BioNTech stock down on muted guidance The stock is being hit because $BNTX did not issue an impressive guidance...
2024-03-20 07:05:16 ET More on BioNTech BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time BioNTech SE (BNTX) 42nd Annual J.P. Morgan Healthcare Conference (Transcript) BioNTech's Strategic Shift: Diversifying Into Cancer Therapeu...
Weir Group plc ADR (WEGRY) is expected to report for Q4 2023 So-Young International Inc. (SY) is expected to report for quarter end 2023-12-31 Atara Biotherapeutics Inc. (ATRA) is expected to report $-0.61 for Q4 2023 Adyen NV ADR (ADYEY) is expected to report for Q4 2023 Five Bel...
2024-03-20 06:22:59 ET More on BioNTech BioNTech Buys Into Autolus' Cell Therapy Tech - Why I Expect A Full Acquisition In Time BioNTech SE (BNTX) 42nd Annual J.P. Morgan Healthcare Conference (Transcript) BioNTech's Strategic Shift: Diversifying Into Cancer Therapeu...
MAINZ, Germany , April 24, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2023 on Monday, May 8 th , 2023. BioNTech invites investors and the gen...
News, Short Squeeze, Breakout and More Instantly...
BioNTech SE Company Name:
BNTX Stock Symbol:
NYSE Market:
Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV (NASDAQ:CVAC) have settled Acuitas’ lawsuit ov...
GSK Plc (NYSE:GSK) has reportedly taken legal action against Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) in a...
Moderna Inc. (NASDAQ:MRNA) is set to clash with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) i...